Insulet CorpPODD
Price$130.79Intrinsic value$354.86171% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.1B+47.4% YoYTTM through 30 Jun 2026
Net Income $375.3M-10.3% YoYTTM through 30 Jun 2026
Free Cash Flow $293.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin69.5%
EBITDA Margin20.1%
Operating Margin16.0%
Net Margin12.3%

Returns

26.4%ROE
11.9%ROA
20.7%ROIC

Balance Sheet Health

Debt / Equity0.73x
Current Ratio2.48x
Net Debt$467.7M
Cash & Equivalents$534.9M

Quality Metrics

Altman Z-Score5.46
Piotroski F-Score6 / 9
FCF Margin9.6%
Rule of 4017.3
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'17'20'21'22'23'24'25
FY2025: $2.7B
Diluted EPS$5.33TTM
'19'20'21'22'23'24'25
FY2025: $3.48

Dividend

No dividend

Capital Allocation

R&D Spend$345.9M
Capex Intensity7.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.